热景生物
(688068)
| 流通市值：81.86亿 | | | 总市值：81.86亿 |
| 流通股本：9275.41万 | | | 总股本：9275.41万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 267,742,855.53 | 116,025,958 | 404,875,328.83 | 309,709,122.21 |
| 营业总成本 | 425,798,962.15 | 205,096,020.9 | 658,410,281.34 | 421,420,697.99 |
| 其他经营收益 | | | | |
| 营业利润 | -158,625,106.46 | -82,241,883.49 | -264,897,517.86 | -111,701,039.27 |
| 利润总额 | -159,611,633.03 | -82,671,395.74 | -267,275,739.98 | -112,139,044.1 |
| 净利润 | -158,809,512.56 | -82,665,618.04 | -258,634,919.3 | -110,481,611.5 |
| 每股收益 | | | | |
| 其他综合收益 | 29,799,414.12 | 2,708,234.04 | 13,420,525.92 | 5,114,949.56 |
| 综合收益总额 | -129,010,098.44 | -79,957,384 | -245,214,393.38 | -105,366,661.94 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,455,679,790.9 | 1,486,228,427.69 | 1,596,987,040.89 | 1,338,817,303.91 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,607,940,624.55 | 1,604,860,449.05 | 1,582,893,150.57 | 1,868,941,711.82 |
| 资产总计 | 3,063,620,415.45 | 3,091,088,876.74 | 3,179,880,191.46 | 3,207,759,015.73 |
| 流动负债: | | | | |
| 流动负债合计 | 179,069,293.37 | 220,593,963.02 | 248,032,642.57 | 264,321,808.38 |
| 非流动负债: | | | | |
| 非流动负债合计 | 293,955,386.61 | 278,891,166.91 | 275,254,908.24 | 13,924,353.66 |
| 负债合计 | 473,024,679.98 | 499,485,129.93 | 523,287,550.81 | 278,246,162.04 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,441,692,411.98 | 2,432,022,948.18 | 2,486,270,782.99 | 2,932,754,189.47 |
| 股东权益合计 | 2,590,595,735.47 | 2,591,603,746.81 | 2,656,592,640.65 | 2,929,512,853.69 |
| 负债和股东权益合计 | 3,063,620,415.45 | 3,091,088,876.74 | 3,179,880,191.46 | 3,207,759,015.73 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 311,830,581.85 | 95,880,455.8 | 514,397,450.58 | 358,256,863.52 |
| 经营活动现金流出小计 | 423,560,057.06 | 156,317,986.08 | 597,754,273.75 | 357,010,849.01 |
| 经营活动产生的现金流量净额 | -111,729,475.21 | -60,437,530.28 | -83,356,823.17 | 1,246,014.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,440,000,526.56 | 919,697,786.32 | 4,995,780,544.64 | 4,015,020,768.95 |
| 投资活动现金流出小计 | 1,648,460,530.76 | 1,208,129,833.5 | 4,746,863,498.85 | 4,145,172,902.69 |
| 投资活动产生的现金流量净额 | -208,460,004.2 | -288,432,047.18 | 248,917,045.79 | -130,152,133.74 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 106,275,682.02 | 8,225,396.97 | 358,861,862.71 | 53,524,377.28 |
| 筹资活动现金流出小计 | 114,753,613.6 | 51,761,761.69 | 271,086,794.66 | 73,187,097.43 |
| 筹资活动产生的现金流量净额 | -8,477,931.58 | -43,536,364.72 | 87,775,068.05 | -19,662,720.15 |
| 汇率变动对现金及现金等价物的影响 | 1,273,186.1 | -3,806,802.41 | 1,457,033.75 | -1,026,246.55 |
| 现金及现金等价物净增加额 | -327,394,224.89 | -396,212,744.59 | 254,792,324.42 | -149,595,085.93 |
| 期末现金及现金等价物余额 | 209,439,139.83 | 111,327,421.44 | 536,833,364.72 | 120,547,844.28 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -327,394,224.89 | - | 254,792,324.42 | - |
最新报告期：2026-08-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东吴证券 | 朱国广 | -0.63 | 0.08 | 0.72 | 2026-08-30 |